Short Interventions to Prevent Trapezius Muscle Fatigue in Computer Work

March 1, 2019 updated by: Swiss Federal Institute of Technology

Trapezius Muscle Fatigue of Long Duration: a Likely Neuromuscular Control Issue

This study is expected to demonstrate that during experimental days of seated computer work sustained and focalized low-level muscle activity contributes to the development of long-lasting fatigue effects (and thus possible disorder). On days with and without frequent interruptions, signs of fatigue and the activity pattern of the trapeze muscle are registered and compared using electromyographic registrations of the trapezius muscle.

Study Overview

Status

Completed

Detailed Description

30 healthy adults without chronic neck pain participated in a laboratory study designed to simulate two full workdays of computer work. Within each session, participants performed five 50-min working activities separated by 10-min breaks: i) Use a computer keyboard to type a text presented on the left side of the screen; ii) do the typing task with the desk height set10 cm above elbow height; iii) play the computer game Spider Solitaire implemented in Windows 10; iv) Stroop test (This test consists of reading the name of a color whose text is in a color different from the name. The color name was then selected from a multiple-choice panel displaying color names; v) the same online puzzle game was presented to all participants. Assembling the puzzle was performed by drag and drop actions. The work periods were not disrupted (on the "control day") whereas two short interruptions of 5-min were introduced at 1/3 and 2/3 of each working period on the "intervention day". During these interruptions, participants were asked to perform "muscle disrupting/relaxing" activities. For each experimental session a 30-min lunch break took place between the third and the fourth work periods. The specific sequence of work activity type and disrupting/relaxing activities was randomized across participants; however, for each participant the order of work activities remained the same for the two experimental sessions (control and intervention days). The order of control and intervention days was also randomized between participants.

A set of six measures were performed at specific time intervals during each experiment: before the first work activity, before and after lunch, immediately and 1 hour after the fifth (last) work activity: i) upper trapezius activation, assessed through the temporal EMG profile recorded by a single bipolar signal; and ii) through the spatio-temporal distribution of EMG activity detected by a 2D array of electrodes (64 channels); iii) muscle fatigue, quantified by changes in electrically induced muscle twitch force signals, iv) isometric performance, v) dynamic performance; iii) cognitive and physical load and stress level. In addition, personality traits (anxiety level), perceived workload and musculoskeletal symptoms were evaluated as covariates.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy experienced computer workers

Exclusion Criteria:

  • chronic pain (more than 30 days within the last 12 months according to the Nordic Questionnaire (Kuorinka et al 1987);
  • pathologies of the neck,
  • prior and actual shoulder or neck pain caused by an accident,
  • skin disease in the neck or shoulder area,
  • BMI > 30,
  • sleep disorders (e.g. apnea, restless legs syndrome),
  • use of medications such as psychotropic drugs, muscle relaxants or analgesics within the last 3 days prior to the experiment,
  • pregnancy.
  • any shoulder/neck pain on the day before the experiment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: short interruptions of work tasks
randomly start with or without short interruptions on the first experimental day and without or with them on the second experimental day

During each activity two interruptions/breaks were selected randomly from a set of ten predetermined actions:

Active break types:

  • Move shoulder and upper back
  • Swing arms near the body
  • Three slow but forceful elevations of the shoulders, a relaxation exercise based on the principles developed by Jacobson
  • Stand up and stretch
  • Slowly turn head in all possible directions.

Passive break types:

  • Tell a couple of jokes
  • Stand up and have a drink
  • Relaxing the trapezius
  • Questions on actual posture and feelings of comfort / discomfort.
  • A short rest on the couch

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EMG profile recorded by a single bipolar electrode: Rest-time
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Rest-time (percentage of time below 5% of the standard activity level). The percentage of registration time without any rest time is called sustained low level muscle activity.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Area of muscle activity
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Area of muscle active region (n. of channels)

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of muscle twitch
Time Frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
3-D muscle twitch acceleration pattern measured at the acromion
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of dynamic force control accuracy
Time Frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in an isometric dynamic tracking task
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EMG profile recorded by a single bipolar electrode: Static activity
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p10 (level of the 10th percentile of the trapezius muscle activity) as an indicator of static activity primarily associated with continuous activity of the same pool of motor units.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Magnitude of activity
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Magnitude of activity of muscle active regions (RMS sEMG).

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Number of active epochs
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Number of active epochs
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of static force control
Time Frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric isotonic low level contraction
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of force control in ramp contraction
Time Frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric ramp contraction.
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Localized musculoskeletal discomfort
Time Frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
head-neck-shoulders-lower back-elbows-wrists-hip-upper legs-knees-ankles-feet-discomfort rated on 10 cm visual analog scales (adapted from Nordic questionnaire (Kuorinka et al 1987)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Visual and general fatigue
Time Frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
10 cm visual analog scales
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Effort
Time Frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
6-20 Borg scale (6= no effort, 20=maximal possible effort)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
EMG profile recorded by a single bipolar electrode: Dynamic activity
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p90 (level of the 90th percentile of the trapezius muscle activity) as an indicator of dynamic activity which may promote variability in the recruitment of motor units
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Centroid of active regions
Time Frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Centroid of active regions
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Läubli, MD, Federal Institute of Technology Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2016

Primary Completion (Actual)

September 5, 2016

Study Completion (Actual)

September 5, 2016

Study Registration Dates

First Submitted

December 14, 2018

First Submitted That Met QC Criteria

March 1, 2019

First Posted (Actual)

March 5, 2019

Study Record Updates

Last Update Posted (Actual)

March 5, 2019

Last Update Submitted That Met QC Criteria

March 1, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 32003B_160207

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Fatigue

Clinical Trials on interruptions of work tasks

Subscribe